Rabeah Al‐Temaimi

1.8k total citations
26 papers, 250 citations indexed

About

Rabeah Al‐Temaimi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Rabeah Al‐Temaimi has authored 26 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Pathology and Forensic Medicine and 6 papers in Cancer Research. Recurrent topics in Rabeah Al‐Temaimi's work include Multiple Sclerosis Research Studies (6 papers), MicroRNA in disease regulation (4 papers) and RNA regulation and disease (3 papers). Rabeah Al‐Temaimi is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), MicroRNA in disease regulation (4 papers) and RNA regulation and disease (3 papers). Rabeah Al‐Temaimi collaborates with scholars based in Kuwait, United Kingdom and Jordan. Rabeah Al‐Temaimi's co-authors include Raed Alroughani, Fahd Al‐Mulla, Ahmad Al‐Serri, Kusum Kapila, Martin J. Woodward, Arnoud H. M. van Vliet, Mohammad Torabi Dashti, Jehad Abubaker, Irina Al‐Khairi and Olusegun A. Mojiminiyi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Rabeah Al‐Temaimi

24 papers receiving 247 citations

Peers

Rabeah Al‐Temaimi
Reyhaneh Salehi-Tabar Canada
Alessia Azzarà Italy
Hongwei Pu China
Nana Ping China
Liang‐Chun Shih Taiwan
Tianming Yu China
Guangying Zheng China
Yuhong Li China
Shangli Liu China
Reyhaneh Salehi-Tabar Canada
Rabeah Al‐Temaimi
Citations per year, relative to Rabeah Al‐Temaimi Rabeah Al‐Temaimi (= 1×) peers Reyhaneh Salehi-Tabar

Countries citing papers authored by Rabeah Al‐Temaimi

Since Specialization
Citations

This map shows the geographic impact of Rabeah Al‐Temaimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabeah Al‐Temaimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabeah Al‐Temaimi more than expected).

Fields of papers citing papers by Rabeah Al‐Temaimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabeah Al‐Temaimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabeah Al‐Temaimi. The network helps show where Rabeah Al‐Temaimi may publish in the future.

Co-authorship network of co-authors of Rabeah Al‐Temaimi

This figure shows the co-authorship network connecting the top 25 collaborators of Rabeah Al‐Temaimi. A scholar is included among the top collaborators of Rabeah Al‐Temaimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabeah Al‐Temaimi. Rabeah Al‐Temaimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Temaimi, Rabeah, Rasheed Ahmad, & Fahd Al‐Mulla. (2025). MMP14 and DDR2 are potential molecular markers for metastatic triple-negative breast cancer. Scientific Reports. 15(1). 21630–21630. 1 indexed citations
2.
Al‐Temaimi, Rabeah, et al.. (2024). Analysis of Candidate miRNAs ' Expression in Pancreatic Cancer. Cancer Medicine. 13(21). e70400–e70400.
3.
Al‐Temaimi, Rabeah & Raed Alroughani. (2024). miR-24-3p and miR-484 are potential biomarkers for neurodegeneration in multiple sclerosis. Heliyon. 10(12). e32685–e32685. 3 indexed citations
4.
Al‐Temaimi, Rabeah, et al.. (2024). Analysis of potential microRNA biomarkers for multiple sclerosis. Experimental and Molecular Pathology. 137. 104903–104903. 2 indexed citations
5.
Al‐Temaimi, Rabeah, et al.. (2023). Uncommon fundus presentation of Koolen-De Vries Syndrome in a young boy. Ophthalmic Genetics. 45(2). 164–166.
6.
Al‐Temaimi, Rabeah & Raed Alroughani. (2022). Dietary Factors Associated with Multiple Sclerosis Risk in Kuwait. International journal of Nutrition Pharmacology Neurological Diseases. 12(3). 200–205. 1 indexed citations
7.
Mojiminiyi, Olusegun A., et al.. (2022). Exploring the relationship between vitamin D and leptin hormones in type 2 diabetes mellitus patients from Kuwait. Hormone Molecular Biology and Clinical Investigation. 43(3). 273–280. 3 indexed citations
8.
Dashti, Mohammad Torabi, et al.. (2020). Replication analysis of variants associated with multiple sclerosis risk. Scientific Reports. 10(1). 7327–7327. 14 indexed citations
9.
Francis, Issam M., et al.. (2019). Vitamin D pathway related polymorphisms and vitamin D receptor expression in breast cancer. International Journal for Vitamin and Nutrition Research. 91(1-2). 124–132. 16 indexed citations
10.
11.
Alroughani, Raed, et al.. (2019). Leptin rs7799039 polymorphism is associated with multiple sclerosis risk in Kuwait. Multiple Sclerosis and Related Disorders. 36. 101409–101409. 12 indexed citations
12.
Al‐Temaimi, Rabeah, et al.. (2019). Thymol tolerance in Escherichia coli induces morphological, metabolic and genetic changes. BMC Microbiology. 19(1). 294–294. 18 indexed citations
13.
Al‐Temaimi, Rabeah, Preethi Cherian, Mohamed Abu‐Farha, & Raed Alroughani. (2019). Angiopoietin-like proteins in multiple sclerosis. Journal of Neuroimmunology. 330. 31–34. 4 indexed citations
14.
Al‐Serri, Ahmad, Raed Alroughani, & Rabeah Al‐Temaimi. (2019). The FTO gene polymorphism rs9939609 is associated with obesity and disability in multiple sclerosis patients. Scientific Reports. 9(1). 19071–19071. 19 indexed citations
15.
Al‐Serri, Ahmad, Suzanne A. Al‐Bustan, Osama Alsmadi, et al.. (2018). Association of <b><i>FTO</i></b> rs9939609 with Obesity in the Kuwaiti Population: A Public Health Concern?. Medical Principles and Practice. 27(2). 145–151. 19 indexed citations
16.
Hatem, Mohamed, et al.. (2017). PLXNA3 Variant rs5945430 is Associated with Severe Clinical Course in Male Multiple Sclerosis Patients. NeuroMolecular Medicine. 19(2-3). 286–292. 6 indexed citations
17.
Al‐Temaimi, Rabeah, Jehad Abubaker, Irina Al‐Khairi, & Raed Alroughani. (2017). Remyelination modulators in multiple sclerosis patients. Experimental and Molecular Pathology. 103(3). 237–241. 14 indexed citations
18.
Alroughani, Raed, et al.. (2017). Assessment of plasma biomarkers for their association with Multiple Sclerosis progression. Journal of Neuroimmunology. 305. 5–8. 10 indexed citations
19.
Al‐Temaimi, Rabeah, et al.. (2016). Epidermal growth factor receptor mutations in nonsmall cell lung carcinoma patients in Kuwait. Journal of Cytology. 33(1). 1–1. 1 indexed citations
20.
Al‐Temaimi, Rabeah, et al.. (2015). The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait. PLoS ONE. 10(11). e0142265–e0142265. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reyhaneh Salehi-Tabar Breakdown of academic impact, for papers by Alessia Azzarà Breakdown of academic impact, for papers by Hongwei Pu Breakdown of academic impact, for papers by Nana Ping Breakdown of academic impact, for papers by Liang‐Chun Shih Breakdown of academic impact, for papers by Tianming Yu Breakdown of academic impact, for papers by Guangying Zheng Breakdown of academic impact, for papers by Yuhong Li Breakdown of academic impact, for papers by Shangli Liu
Rankless by CCL
2026